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Background. Rational and appropriate use of antibiotics is a global priority since inappropriate or unnecessary use is associated with antibiotic resistance and patient morbidity. In adult patients, the presence of a β-lactam allergy label (BLA) often leads to the use of broader spectrum agents with more toxicity. Infections account for a majority of pediatric hospital admissions, and β-lactam antibiotics are often considered first-line therapy. There is limited evidence on the impact of BLA on prescribing practices in pediatrics. The primary objective of this study was to determine the proportion of children with a reported BLA who received second-line antimicrobials (as determined by hospital empiric antibiotic guidelines). The secondary objective was to identify patient characteristics associated with receiving second-line antibiotics.
Methods. A 1-year retrospective cohort study was undertaken at the Hospital for Sick Children. We reviewed the characteristics and management of patients with a reported BLA who received antibiotics from January to December 2016.
Results. Of the 16,224 admissions in 2016, 206 patients with a reported BLA received antibiotics. Among these patients, the median age was 7.9 years (IQR 4.0, 12.8) and the majority of patients had at least one medical condition (n = 120, 59.3%), including 27 children with complex medical or genetic conditions (13.1%). Penicillin (n = 86, 41.8%) and amoxicillin (n = 70, 33.9%) were the most commonly reported allergens. Nonsevere rashes were the most commonly reported allergic reactions (n = 158, 73.1%). Ninety-four patients (46%; 95% CI (0.39,0.52) received second-line therapy. After adjusting for age and sex, the odds of receiving a second-line antibiotic were increased in patients with any underlying medical condition (OR = 2.45, 95% CI 1.32-4.56), had a reported allergic reaction that was deemed high-risk (i.e., anaphylaxis, respiratory or systemic symptoms, severe rashes) (OR = 2.61, 95% CI 1.11-6.11) or who received antibiotics for surgical prophylaxis (OR = 3.30, 95% CI 1.44-7.54).
Conclusion. Almost half of pediatric patients with a reported BLA received a second-line antibiotic when compared with hospital empiric antibiotic guidelines. There is a need for a systematic approach to evaluating reported BLA in order to promote judicious prescribing habits.
Disclosures. All authors: No reported disclosures. Thursday, October 4, 2018: 12:30 PM Background. Multiplex PCR (mPCR) can be used to rapidly identify polymicrobial blood stream infections (BSIs) and guide empiric therapy. In addition rapid identification of potential contaminants, may limit unnecessarily broad empiric therapy. The purpose of this study was to describe the use of mPCR to diagnosis polymicrobial BSIs in hospitalized children, and the impact of this technology on antibiotic prescribing.
Diagnosis and Management of Polymicrobial Blood Stream Infections With Multiplex PCR in Hospitalized Children
Methods. We retrospectively identified children at our institution with polymicrobial BSIs diagnosed by mPCR (Film Array Blood Culture Identification Panel, BioFire Diagnostics) from October 2014 to March 2018. A polymicrobial BSI was defined as any blood isolate with ≥1 bacterial or fungal species. Gram stain results, species identification by mPCR, and final species identification via matrix associated laser deionization time of flight (MALDI-TOF) were determined. Antibiotic prescribing for treatment of each BSI was reviewed.
Results. Overall, 622 patients experienced 961 blood stream infections. There were 54 patients who experienced 68 polymicrobial BSIs (7%). Of the polymicrobial BSIs, 55 (80.9%) were two organisms and 13 (19.1%) were three or more organisms. Of the 68, 44 (64.7%) had the same Gram stain morphology and 24 (35.3%) had different morphology. Antibiotic therapy was broadened, narrowed, and unchanged in 38 (56%), 16 (24%), 14 (21%) of infections, respectively. Common modifications of therapy included addition of aminoglycoside or meropenem when two Gram-negative bacilli were present, and addition of vancomycin when coagulase negative staphylococci (CoNS) were isolated.
Conclusion. The use of mPCR commonly led to prompt modification of antibiotic therapy to treat polymicrobial blood stream infections. Identification of CoNS frequently led to broadening of antibiotic therapy, even when other organisms were present.
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